发明名称 |
METHODS AND COMPOUNDS FOR THE GENETIC TREATMENT OF HYPERLIPIDEMIA |
摘要 |
The present invention concerns the introduction of specific alterations in the genes that encode three apolipoproteins, Apo A1, Apo B and Apo E. The alternations in Apo A1 introduce a cysteine residue so the disulfide crosslinked Apo A1 homodimers and Apo A1/A2 heterodimers can be formed. The alterations in Apo B introduce stop codons or frame shift mutations that cause the production of a truncated Apo B protein. The alterations in Apo E introduce specific point mutations that have been identified as protective. The production in the liver of a subject of these altered proteins reduces the risk of the subjects developing atherosclerosis. In one embodiment the genetic alterations are introduced by use of chimeric, mixed RNA/DNA, duplex oligonucleotides.
|
申请公布号 |
CA2320965(A1) |
申请公布日期 |
1999.08.19 |
申请号 |
CA19982320965 |
申请日期 |
1998.08.28 |
申请人 |
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY;THE REGENTS OF THE UNIVERSITY OF MINNESOTA |
发明人 |
ROY-CHOWDHURY, JAYANTA;BANDYOPADHYAY, PARAMITA T.;KREN, BETSY T.;STEER, CLIFFORD J. |
分类号 |
C12N15/09;A01N43/04;A61K9/127;A61K9/50;A61K9/51;A61K31/7088;A61K31/7105;A61K31/711;A61K31/712;A61K31/7125;A61K47/24;A61K48/00;A61P3/06;C07H21/00;C07H21/04;C12N15/11;C12N15/85;C12Q1/68;(IPC1-7):A01N43/04 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|